Navitas Life Sciences

It’s now time for your OPDP Submissions to be FDA Compliant – Are you Ready?

Authored by our Senior Manager – Regulatory Operations, Prabu Selvaraj, we are delighted to have had this article published in the peer reviewed International Pharmaceutical Industry journal. The article explores the considerations when submitting a 2253 submission and accelerated pre-submission following the FDA mandate around OPDP submissions in June 2021. Are you ready?

Please complete the form to download a copy of the article and learn more.

Please complete the form to download a copy of the article.

Published in International Pharmaceutical Industry Issue 4 | Issue4 | November, 2021 | Pages 18 - 20

International Pharmaceutical Industry

Please complete form to download PDF
First Name
Last Name
Business Email
Job Title
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy

© 2021 Navitas Life Sciences | Privacy Policy